Provident Investment Management Inc. decreased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 0.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 160,319 shares of the pharmaceutical company’s stock after selling 850 shares during the quarter. Vertex […]